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Bone morphogenetic protein (BMP) inhibition has been proposed as the primary determinant of neural cell fate in the developing Xenopus
ectoderm. The evidence supporting this hypothesis comes from experiments in explanted banimal capQ ectoderm and in intact embryos using
BMP antagonists that are unregulated and active well before gastrulation. While informative, these experiments cannot answer questions
regarding the timing of signals and the behavior of cells in the more complex environment of the embryo. To examine the effects of BMP
antagonism at defined times in intact embryos, we have generated a novel, two-component system for conditional BMP inhibition. We find
that while blocking BMP signals induces ectopic neural tissue both in animal caps and in vivo, in intact embryos, it can only do so prior to
late blastula stage (stage 9), well before the onset of gastrulation. Later inhibition does not induce neural identity, but does induce ectopic
neural crest, suggesting that BMP antagonists play temporally distinct roles in establishing neural and neural crest identity. By combining
BMP inhibition with fibroblast growth factor (FGF) activation, the neural inductive response in whole embryos is greatly enhanced and is no
longer limited to pre-gastrula ectoderm. Thus, BMP inhibition during gastrulation is insufficient for neural induction in intact embryos,
arguing against a BMP gradient as the sole determinant of ectodermal cell fate in the frog.
D 2004 Elsevier Inc. All rights reserved.
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Signaling by the bone morphogenetic proteins (BMPs), a
subset of the TGF-h superfamily of cytokines, has been
implicated in numerous developmental processes, including
patterning of the limb, tooth, kidney, and somites (Zhao,
2003). BMPs bind as dimers to two classes of serine-
threonine kinase receptors, designated type I and type II
(Massague et al., 2000; Shi and Massague, 2003; Whitman,
1998). Upon ligand binding, activated type II receptors
transphosphorylate type I receptors, which propagate the
signal by phosphorylating receptor regulated Smad (R-
Smad) proteins. Within the TGF-h family, BMP receptors0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.10.002
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while the receptors for nodal-like ligands phosphorylate
Smad2 or Smad3.
BMPs are critical in the differentiation of pluripotent
ectodermal cells, and have been proposed as the primary
determinant of neural identity (Hawley et al., 1995; Liem et
al., 1995; Wilson and Hemmati-Brivanlou, 1995). In frogs,
the organizer expresses secreted BMP antagonists, and
blocking BMP signaling in vivo or in ectodermal explants
induces neural differentiation (Lamb et al., 1993; Piccolo et
al., 1996; Sasai et al., 1995; Zimmerman et al., 1996). In situ
observations reveal high BMP activity in the ventral
ectoderm and low activity in dorsal ectoderm (Faure et al.,
2000; Kurata et al., 2001; Schohl and Fagotto, 2002), and
studies in animal caps indicate that discrete BMP signaling
levels induce three cell identities within the early ectoderm:
epidermis, neural crest, and neural (Marchant et al., 1998;
Wilson et al., 1997). Collectively, these observations277 (2005) 425–442
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antagonists establish an activity gradient in the ectoderm. In
this model, low BMP signaling near the organizer specifies
neural cell fate in the dorsal ectoderm, intermediate BMP
levels induce neural crest in the marginal ectoderm, and
high BMP activity results in epidermal fate in the ventral
ectoderm.
Despite the evidence for a functional BMP gradient,
several observations suggest a more complicated mecha-
nism for determining neural and neural crest fate. Some
neural-inducing genes are expressed prior to organizer
formation, and neural tissue can be induced in the absence
of a definitive organizer (Kroll et al., 1998; Kuroda et al.,
2004; Mizuseki et al., 1998; Penzel et al., 1997; Wessely
et al., 2001). In avian embryos, BMP inhibitors fail to
induce neural identity in blastula or gastrula stage non-
neural ectoderm, though BMP activity is excluded from
the presumptive neural plate during gastrulation and
activation of BMP signaling represses neural formation
(Faure et al., 2002; Levin, 1998; Storey et al., 1992; Streit
and Stern, 1999; Streit et al., 1998, 2000; Wilson et al.,
2000, 2001). Together, these data suggest that neural
induction may be governed by the integration of multiple
signaling mechanisms.
Members of the fibroblast growth factor (FGF) family of
growth factors have emerged as important candidates for
regulators of additional signaling important for neural
induction. FGFs have been implicated in neural induction
and patterning in a variety of organisms (Domingos et al.,
2001; Holowacz and Sokol, 1999; Hongo et al., 1999;
Ishimura et al., 2000; Koshida et al., 2002; Ribisi et al.,
2000; Streit and Stern, 1999; Wilson et al., 2000), and FGFs
and BMPs act antagonistically in the development of a
variety of embryonic structures (Bei and Maas, 1998; Chen
et al., 2000; Zuniga et al., 1999). Furthermore, MAP Kinase
(MAPK), a transducer of FGF signaling, phosphorylates
several serine residues in the linker region of Smad1, and
Smad1 mutations that block MAPK-dependent phosphor-
ylation act as dominant negative inhibitors of neural
development (Kretzschmar et al., 1997a; Pera et al., 2003;
Sater et al., 2003). These experiments suggest that cross-
regulation of BMP and FGF signaling pathways, as well as
independent action by each, may be an important compo-
nent of neural induction.
Much of the experimental confirmation for the BMP
gradient model in frogs relies on two methods: BMP
inhibitors injected as mRNA into early cleavage-stage
embryos and explanted ectodermal tissue (banimal capsQ).
However, injection of inhibitors may affect early patterning,
as their consequent BMP antagonism begins by the 16–32
cell stage. While banimal capsQ provide an elegant method
for examining early ectoderm patterning, they also isolate
the ectoderm from adjacent tissues, potentially removing
some of the signals that modulate ectodermal identity. In
addition, the process of animal cap isolation, particularly if
it is coupled to partial dissociation of cells to allow exposureto extracellular factors, introduces a set of perturbations that
may not reflect endogenous physiology. Therefore, to more
accurately characterize the function of BMP signaling
during Xenopus neural determination, BMP antagonism
should be carried out in a stage-specific manner in intact
embryos.
Conditional regulation of transcription factor function
can be achieved in Xenopus by generating fusion proteins
to the hormone-binding domain of the glucocorticoid
receptor (GR) (Kolm and Sive, 1995). Such proteins are
held inactive until the addition of the hormone dexame-
thasone (DEX). We reasoned that fusion of the GR
hormone-binding domain to a cytoplasmic antagonist of
BMP signaling might allow similar conditional regulation
of the BMP pathway. Among the regulators of BMP
signaling, the inhibitory Smads, Smad6 and Smad7, both
act in the cytoplasm (Bhushan et al., 1998; Casellas and
Brivanlou, 1998; Hata et al., 1998). Smad6 specifically
blocks signaling by the BMP/GDF pathway, at least in part
by binding to phosphorylated Smad1 and competing with
Smad4 (Hata et al., 1998). Smad7 antagonizes both BMP
and nodal-like signaling by binding to type I receptors and
inducing their degradation (Kavsak et al., 2000; Suzuki et
al., 2002). However, misexpression of the C-terminal half
of Smad7 elicits phenotypes suggesting BMP-specific
inhibition (Nakayama et al., 2001); its action at the level
of the receptor furthermore suggests that it should be
possible to track the effectiveness of DSmad7 as an
inhibitor of endogenous signals by examining receptor-
dependent Smad phosphorylation.
We report here the construction of a tightly controlled
conditional BMP inhibitor, combining a GR regulated
DSmad7 with a novel regulated form of the tobacco etch
virus (TEV) protease. We have confirmed the effectiveness,
specificity, and regulation of this inhibitor by examination
of endogenous Smad phosphorylation using phosphoSmad
antibodies (Faure et al., 2000). Using this inhibitor, we have
examined the consequences of stage-specific BMP antago-
nism on neural and neural crest induction. Consistent with
previous studies, BMP inhibition induces expression of
neural markers in explanted gastrula-stage Xenopus ecto-
derm (Hawley et al., 1995; Knecht et al., 1995; Lamb and
Harland, 1995; Lamb et al., 1993; Wilson and Hemmati-
Brivanlou, 1995). In intact embryos, early BMP inhibition
also induces ectopic neural tissue, yet this capacity is lost
prior to gastrulation, as BMP inhibition after mid-blastula
stage (stage 8) fails to cause ectopic neural induction. While
later inhibition does not induce neural identity, it does
induce ectopic neural crest, suggesting that BMP-dependent
neural and neural crest specification occur at different times.
We also find that co-activation of FGF signaling greatly
enhances BMP antagonist-mediated neural induction. Fur-
thermore, unlike BMP antagonism alone, the combination
of BMP inhibition and FGF activation can drive neural
induction both before and after the onset of gastrulation in
whole embryos and in stage 11 animal caps. These results
S. Wawersik et al. / Developmental Biology 277 (2005) 425–442 427indicate that in the intact frog embryo, as in chick, BMP
inhibition by itself is insufficient for neural induction. This
argues against a BMP antagonism as the sole determinant of
early ectodermal cell identity, suggesting a more complex
model where extra-ectodermal signals modulate neural
induction through interactions between the BMP and FGF
signaling pathways.Materials and methods
Cloning of expression constructs
DNA encoding DSmad7 was amplified from Xenopus
Smad7 (a gift of A. Hemmati-Brivanlou) by PCR using the
following primers: DSm7-up 5V-TTC GAA TTC CAT GGA
CTT TCT CAA ACC C-3V; DSm7-dn 5V-CAC TAT AGT
TCT AGA GGC TCG AGT CCG CGG-3V. These primers
contain an EcoRI site in the upstream primer and an XhoI
site in the downstream one, and these restriction sites were
used to clone DSmad7 into pCS2-based expression vectors.
To insert three tobacco etch virus (TEV) protease
cleavage sites between DSmad7 and the C-terminal gluco-
corticoid receptor (GR) domain, two complimentary oligos
were synthesized: 3TEVsense 5V-TCG AGA ACC TAT
ACT TCC AAG GTG AAG GCC TAT ACT TCC AGG
GTG AGA ATC TGT ATT TCC AAG GT-3V and
3TEVantisense 5V-CTA GAC CTT GGA AAT ACA GAT
TCT CAC CCT GGA AGT ATA GGC CTT CAC CTT
GGA AGT ATA GGT TC-3V. These were mixed at 500 Ag/
Al (each oligo) in 100 mM NaCl, heated to 858C, and
allowed to cool gradually to room temperature. The
annealed oligos create sticky ends compatible with an XhoI
site on the 5V end and an NheI site on the 3V end, and these
sites were used to ligate the oligo in between the DSmad7
and GR coding regions of the DSmad7GR DNA.
The TEV2GR construct was generated using PCR to
insert an EcoRI site upstream and an XhoI site downstream
of the DNA encoding the TEV protease (Lucast et al., 2001)
(Primers: TEV-up 5V-AAG AGG AGG AAT TCC ATG
GCT GAA AGC-3V; TEV-dn 5V-TGG TGATGG TGC TCG
AGC AAT TCC GAG-3V). These were used to clone the
protease into pCS2-based expression vectors.
Western blot analysis
Embryos were homogenized (20 Al/embryo) in a
modified RIPA buffer (150 mM Tris–HCl, pH 8, 150 mM
NaCl, 1% NP-40, 0.5% deoxycholate, 2 mM EDTA, 25
mM h-glycerophosphate, 100 mM NaF, 2 mM sodium
orthovanadate, 10 mM sodium pyrophosphate, 20 nM
calyculin A, 2 complete protease inhibitor cocktail
(Roche), 4 Ag/ml pepstatin A, 1 mM PMSF) and
centrifuged for 10 min at 14,000  g (48C). The super-
natant was removed and suspended in an equal volume of
2 Laemmli loading buffer. Lysates were separated by7.5% SDS-PAGE and transferred to nitrocellulose (Protran).
Membranes were blocked with 1% polyvinyl pyrrolidone
(PVP) (Sigma) in TBST (except for anti-pSmad2, which
was blocked in 5% PVP + 0.01% thimerosal overnight at
room temperature), then incubated overnight at 48C with
primary antibody under the following conditions: anti-
pSmad1 (Faure et al., 2000) 1:200 in TBST + 0.1% BSA,
anti-Smad2 (Faure et al., 2000) 1:500 in TBST, anti-actin
(Sigma) 1:1000 in TBST, anti-myc (Santa Cruz) 1:1000 in
TBST + 5% nonfat dry milk. After several washes in TBST,
blots were incubated with HRP conjugated secondary
antibody for 1–2 h at RT, washed several times in TBST,
and HRP activity was detected by chemiluminescence
(Amersham).
Embryo manipulations
Embryos were collected from Xenopus females and
artificially fertilized as previously described (Watanabe
and Whitman, 1999). Staging of embryos was according
to Nieuwkoop and Faber (1967). Prior to first cleavage,
embryos were dejellied in 2% cysteine (pH 7.5). To aid
visualization of anatomical features, albino embryos were
stained in 0.5% Nile Blue in 0.1 MMR, followed by
several washes in 0.1 MMR. Embryos were placed in 3%
ficoll, 1 MMR and injected at 2-, 4-, or 8-cell stage with
10 nl RNA. Following injection, embryos were kept in ficoll
at 148C for 1–2 h before being placed in 0.1 MMR.
Animal cap dissections were performed in 0.7 MMR and
caps were kept in 0.7 MMR until they were collected.
Where noted, Dexamethasone (DEX) (Sigma) was added to
culture medium at a concentration of 10 AM (Stock: 10 mM
in EtOH). AP20187 (ARIAD Pharmaceuticals) was added at
a concentration of 1.25 AM (Stock: 1.25 mM in EtOH).
SU5402 (Calbiochem) was added to embryo culture
medium at a concentration of 20 AM (Stock: 2 mM in
DMSO).
Whole mount immunostaining
Embryos were collected and fixed for 1 h at room
temp in MEMFA (0.1 M MOPS, pH 7.4, 2 mM EGTA,
pH 8, 1 mM MgSO4, 3.7% formaldehyde) then incubated
for 10 min in 100 mM lysine in PBS + 0.1% Tween
(PBS-Tween) at RT. Embryos were washed several times
in PBT (PBS, 2 mg/ml BSA, 0.1% Triton X-100) and
stored in PBT at 48C for no longer than 24 h prior to
immunostaining. Prior to immunostaining, embryos were
blocked in 10% normal goat serum (NGS) (Jackson
Immunoresearch) in PBT. Embryos were incubated in
1:20 dilution of anti-pSmad1 antibody in 10% NGS
overnight at 48C, washed six times for 15 min each in
PBT, then incubated with HRP conjugated secondary
antibody (1:250). Staining was developed using an
ImmunoPure Metal-enhanced DAB Kit (Pierce), as per
manufacturer’s instructions for 15–20 min.
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Embryos were fixed in MEMFA as described above.
Where h-galactosidase staining was performed, embryos
were incubated in 1 mg/ml magenta-gal (ICN) in 20 mM
K3Fe(CN)6, 20 mM K4Fe(CN)6d 3H2O, 2 mM MgCl2,
0.01% sodium deoxycholate and 0.02% NP-40 at room
temperature. In situ hybridizations were performed as
previously described (Wawersik et al., 1999), with the
following modifications: embryos were permeabilized for
30 min in RIPA (150 mM NaCl, 1% NP-40, 0.5%
deoxycholate, 1 mM EDTA, 50 mM Tris–HCl pH 8.0),
followed by 20 min fixation in MEMFA. Hybridization and
washes were done at 608C. Alkaline phosphate staining
carried out overnight at 48C in the dark in BM Purple
(Roche) supplemented with 2 mM levamisole. After color
development, embryos were fixed for 2 h in MEMFA at RT
and stored in PBS.
RT-PCR analysis
Collection of RNA and generation of cDNA was
performed as previously described (Watanabe and Whitman,
1999). The following primers were used: NCAM forward 5V-
CACAGTTCCACCAAATGC-3V; NCAM reverse 5V-GGA
ATC AAG CGG TAC AGA-3V; EF-1a forward 5V-CAG ATT
GGT GCT GGA TAT GC-3V; EF-1a reverse 5V-ACT GCC
TTG ATG ACT CCT AG-3V; Sox2 forward 5’-GAG GAT
GGA CAC TTATGC CCA C-3V; Sox2 reverse 5V-GGA CAT
GCT GTA GGT AGG CGA-3V. PCR conditions: 22 cycles,
958C 30 s, 558C 30 s, 728C 45 s.
Imaging
Embryos were photographed using a Leica MZFLII
stereomicroscope and a MagnaFire SP digital camera
(Optronics). In some cases, after image capture, image
brightness and color balance were slightly modified using
Photoshop 7 (Adobe).Results
The C-terminal fragment of Smad7, DSmad7, inhibits
phosphorylation of Smad1, but not of Smad2
Misexpression of the C-terminal half of Smad7 (DSmad7,
Fig. 1A) in Xenopus embryos produces phenotypes similar
to those observed upon ectopic BMP inhibition, suggesting
that DSmad7 may specifically inhibit BMP signaling
(Nakayama et al., 2001). To formally test this hypothesis,
we injected RNA encoding DSmad7 into embryos and
examined the phosphorylation states of R-Smads in stage
10+ embryos using phosphorylation-specific antibodies to
the BMP- and nodal-dependent Smads (Faure et al., 2000).
Note that the BMP receptors phosphorylate identical aminoacid sequences at the C-termini of Smads 1, 5, and 8
(Hoodless et al., 1996; Kretzschmar et al., 1997b; Macias-
Silva et al., 1998). Consequently, our phospho-specific
antibody cannot distinguish between these Smads, and we
will therefore refer to the BMP-regulated R-Smads in frog
simply as dSmad1.T Injection of RNA encoding a constitu-
tively active type I BMP receptor (ALK2*) induces Smad1
phosphorylation but does not affect phosphorylation of the
nodal-regulated R-Smad, Smad2 (Fig. 1B). Injection of RNA
encoding the BMP antagonist noggin also does not affect
Smad2 phosphorylation but specifically inhibits Smad1
phosphorylation. Injecting increasing amounts of DSmad7
RNA inhibits Smad1 phosphorylation in a concentration-
dependent manner without affecting Smad2 phosphoryla-
tion. To further test whether DSmad7-mediated inhibition is
specific to phospho-Smad1, we activated the Smad2 path-
way by injecting RNA encoding the Nodal-like ligand Xnr1
(Jones et al., 1995; Lustig et al., 1996; Smith et al., 1995),
then tested the effects of high concentrations of DSmad7 on
Smad1 and Smad2 phosphorylation (Fig. 1C). Injection of
either 200 or 800 pg of DSmad7 RNA blocks Smad1
phosphorylation, but does not affect Smad2 phosphoryla-
tion. DSmad7 can antagonize nodal-like signaling at high
concentrations, as phospho-Smad2 signaling is reduced upon
injection of 1.6 ng of DSmad7. However, this amount of
DSmad7 is more than 10-fold higher than that required to
inhibit phospho-Smad1, suggesting that, at the concentra-
tions used in subsequent experiments, the C-terminal frag-
ment of Smad7 specifically inhibits BMP signaling without
affecting activation of the nodal-like pathway.
Generation of a hormone-inducible inhibitor of BMP
signaling
In Xenopus, transcription factor function can be condi-
tionally regulated by fusion to the hormone-binding domain
of the glucocorticoid receptor (GR) (Kolm and Sive, 1995).
Such proteins are held inactive until the addition of the
hormone dexamethasone (DEX). While we find that
addition of a GR domain to the C-terminus of DSmad7
(DSmad7GR, Fig. 1A) confers some conditional regulation
(data not shown), DEX-induced phospho-Smad1 inhibition
is only observed at high DSmad7GR concentrations,
suggesting that the GR domain reduces DSmad7 activity
in the presence of DEX. However, in the absence of DEX,
these same DSmad7GR concentrations weakly inhibit
Smad1 phosphorylation and produce significant phenotypic
abnormalities (data not shown). Thus, a usable conditional
inhibitor requires either tighter DSmad7 regulation in the
absence of DEX or increased DSmad7 activity upon DEX
addition.
To alleviate interference with activated DSmad7GR
function, we devised a means to remove the GR domain in
vivo. We generated a hormone inducible tobacco etch virus
(TEV) NIa protease by fusing GR domains onto both the N-
and C-termini (TEV2GR, Fig. 1A). The TEV NIa protease
Fig. 1. DSmad73TEVGR is an inducible inhibitor of Smad1 phosphorylation. (A) Diagram of inducible inhibitor constructs. DSmad7 is a deletion of the MH1
domain of Xenopus Smad7, using the methionine at amino acid 172 as a start codon. A glucocorticoid receptor domain is fused to the C terminus of DSmad7 in
the DSmad7GR construct. In the MTDSmad73TEVGR construct, three cleavage sites for the tobacco etch virus (TEV) protease are inserted between the C
terminus of DSmad7 and the GR domain, and a myc tag is added to the N-terminus. The dexamethasone (DEX) inducible TEV protease (TEV2GR) consists of
two GR domains flanking the TEV protease itself. (B) DSmad7 inhibits phosphorylation of Smad1, but not of Smad2. Lysates from uninjected St. 10.5
embryos or from embryos injected at the animal pole at the two-cell stage with mRNA encoding activated ALK2 (ALK2*; 100 pg/embryo), noggin (100 pg/
embryo), or increasing amounts of DSmad7 were analyzed by Western blot with anti-phosphoSmad1 and anti-phosphoSmad2 antibodies. Cytoskeletal actin
served as a loading control. (C) DSmad7 inhibits Smad1 phosphorylation but causes no reduction in Xnr1 stimulated Smad2 phosphorylation. Embryos were
analyzed as in (B), after injection at the 2-cell stage with the indicated doses of RNA encoding Xnr1 or DSmad7 (D) TEV2GR cleaves the GR domain from
DSmad73TEVGR in a regulated manner. N-terminal myc tags were added to DSmad7 and DSmad73TEVGR, and mRNA encoding these proteins were
injected into two-cell stage embryos (DSmad7: 100 pg/embryo; DSmad73TEVGR: 300 pg/embryo, along with increasing amounts of TEV2GR. 10 AM DEX
was added to embryos at the 8-cell stage. After lysis at St. 10.5, accumulation of the cleaved form of DSmad73TEVGR was analyzed by Western blotting with
an anti-myc antibody, while concomitant inhibition of Smad1 phosphorylation was assessed using the anti-phosphoSmad1 antibody.
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X-QAS/G (Kapust et al., 2001; Lucast et al., 2001), and we
inserted three of these cleavage sites in tandem between the
DSmad7 and the GR coding domains (DSmad7tevGR). We
hypothesized that upon DEX addition, TEV2GR would
cleave the GR domain from DSmad7tevGR, removing
interference by the GR domain on DSmad7 activity. Such
increased activity might require injection of less
DSmad7tevGR RNA, reducing the leaky activation in the
absence of DEX.
To test this, we injected 300 pg of RNA encoding
DSmad7tevGR into embryos, together with several concen-
trations of TEV2GR. A myc tag was added to the N-termini
of DSmad7 and of DSmad7tevGR, and Western blots using
an antibody to this tag show increased accumulation of the
cleaved form of DSmad7tevGR in the presence of DEX(Fig. 1D). Ten picograms of TEV2GR RNA cause little
accumulation of cleaved DSmad7tevGR in the absence of
DEX, but is sufficient to induce both cleavage of
DSmad7tevGR and inhibition of Smad1 phosphorylation
upon DEX addition.
We also functionally tested whether DSmad7tevGR/
TEV2GR exhibited leaky activation by examining their
effect on embryonic development. Two hundred, 300, or
400 pg of DSmad7tevGR RNA were injected with 10 pg
TEV2GR RNA, and the resulting embryos were allowed to
develop to tailbud stage (Fig. 2). In the absence of DEX,
embryos injected with 200 or 300 pg DSmad7tevGR and 10
pg TEV2GR are phenotypically comparable to uninjected
controls (compare Figs. 2B and C with A), while increasing
the DSmad7tevGR RNA concentration to 400 pg causes
head defects, weak dorsalization, and occasional axis
Fig. 3. Inhibition of pSmad1 occurs rapidly after DEX addition. (A) RNA
was into both cells of two-cell stage embryos, animal cap explants were
isolated at stage 8 and DEX was added when sibling embryos were at either
stage 9 or stage 11. The caps were then allowed to develop overnight at
148C, until sibling embryos had reached stage 16, when they were
harvested and phosphoSmad1 levels were analyzed by Western blot. (B)
mRNA encoding 300 pg DSmad73TEVGR and 10 pg TEV2GR was
injected into both cells at the two-cell stage. Animal caps were isolated and
assayed by Western blot with anti-phosphoSmad1 antibody. Cytoskeletal
actin was used as a loading control. Culture of embryos and caps was
carried out at 148C. DEX was added either before caps were cut (St. 5) or 6,
3, 2, and 1 h before harvesting at stage 10. One hour after DEX addition,
pSmad1 inhibition is substantially inhibited. By 3 h after addition, pSmad1
levels are equivalent to that observed in caps from embryos to which DEX
was added at stage 5.
Fig. 2. Phenotypic consequences of DSmad7TEVGR/TEV2GR expression in the absence and presence of DEX. Phenotypes of uninjected embryos (A) or
embryos injected with 200 pg (B), 300 pg (C) or 400 pg (D) DSmad7TEVGR mRNA together with 10 pg TEV2GR mRNA. Note the head defects and partial
duplication of axes at the highest concentration of DSmad7TEVGR (arrows, D). In the presence of 10 AMDEX, uninjected embryos are phenotypically normal
(E), but injected embryos show defects reflecting dorsalization of the embryo (F–H).
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embryos at all concentrations tested (Figs. 2F–H), with
effects ranging from moderate at 200 pg DSmad7tevGR to
severe at 400 pg. Though DEX-induced embryos at 300 pg
DSmad7tevGR/10 pg TEV2GR are not as severely affected
as those at higher concentrations (compare Figs. 2G with
H), 300 pg is the highest concentration examined at which
uninduced embryos show no unusual phenotypes. There-
fore, all subsequent experiments were carried out using 300
pg DSmad7tevGR and 10 pg TEV2GR, which function
together as a potent, tightly regulated conditional inhibitor
of BMP signaling through Smad1.
Inhibition by DSmad7tevGR/TEV2GR can be rapidly
activated at multiple stages of development
To examine whether DSmad7tevGR/TEV2GR-mediated
phosphoSmad1 inhibition can be activated at multiple stages
of development, we injected RNA into both cells of two-cell
stage embryos. From these embryos, animal cap explants
were isolated at stage 8 and DEX was added when sibling
embryos were at either stage 9 or stage 11. The caps were
then allowed to develop overnight at 148C, until sibling
embryos had reached stage 16, when they were harvested
and phosphoSmad1 levels were analyzed by Western blot
(Fig. 3A). Phospho-Smad1 inhibition was not observed in
caps in the absence of DEX. Addition of DEX at either stage
9 or stage 11 resulted in pSmad1 inhibition comparable to
that in caps from embryos where DEX was added at stage 5.
These results indicate that BMP antagonism by
DSmad7tevGR/TEV2GR is equally efficient when DEX is
added to ectoderm before or after the onset of gastrulation.
The delay between DEX addition and maximal BMP
inhibition was tested by injecting DSmad7tevGR/TEV2GR
RNA into both cells of two-cell stage embryos. Animal caps
were isolated from these embryos at stage 9 and allowed to
develop at 148C for 6 h. DEX was added 1, 2, 3, or 6 h
before harvesting, and both phosphoSmad1 levels andaccumulation of cleaved DSmad7tevGR were analyzed by
Western blot (Fig. 3B). One hour after the addition of DEX,
some pSmad1 inhibition is observed. Interestingly, little
accumulation of cleaved DSmad7tevGR is observed in these
samples, suggesting that the uncleaved form may mediate
initial pSmad1 inhibition. Significant accumulation of
Fig. 4. Stage-dependent neural induction in isolated embryonic ectoderm.
Neural induction in embryos injected with 300 pg DSmad7TEVGR and
10 pg TEV2GR was examined by RT-PCR for N-CAM or Sox-2 (A) or in
situ hybridization for Sox2 (B–F). (A) Addition of DEX induces strong
neural expression in caps from embryos to which DEX was added at stage
4. Neural markers are also up-regulated upon addition of DEX at stage 9,
though the neural response is decreased. Neural marker expression is absent
in caps to which DEX is added at stage 11. (B) Little or no Sox2 expression
is observed in h-gal-injected caps or in DSmad7TEVGR/TEV2GR-injected
caps to which no DEX was added (C). Caps from DSmad7TEVGR/
TEV2GR-injected embryos to which DEX was added at stage 4 show
strong Sox2 upregulation (D). Up-regulation of Sox2 is diminished in
DSmad7TEVGR/TEV2GR-injected caps to which Dex was added at stage
9 (E), and absent upon addition of DEX at stage 11 (F). (A) This effect was
also observed by RT-PCR. Little induction of the neural markers Sox2 or
NCAM is observed in the absence of DEX.
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to that in caps from embryos to which DEX was added at
stage 5 is evident by 3 h after DEX addition. At 148C, stages
8, 9, and 10 are separated by roughly 6 h each (Nieuwkoop
and Faber, 1967), suggesting that at this temperature, the
delay in BMP inhibition is short enough to allow dissection
of stage-specific requirements for BMP signaling. There-
fore, all subsequent experiments were carried out in
embryos or animal caps incubated at 148C.
Regulated DSmad7 induces neural markers in explanted
ectoderm
Addition of noggin protein, a secreted BMP antagonist,
induces neural marker expression in explanted ectoderm
when added before stage 10.5 (Knecht et al., 1995; Lamb et
al., 1993). We therefore tested the ability of regulated
DSmad7 to similarly induce neural expression in animal
caps. RNA encoding DSmad7tevGR and TEV2GR was
injected into both cells of two-cell stage embryos. Animal
caps were cut at stage 8, and DEX was added to caps when
sibling embryos reached stage 9 or stage 11. Caps to which
DEX was not added and caps cut from embryos to which
DEX was added at stage 4 served as negative and positive
controls, respectively. When sibling embryos reached stage
16, RNA was collected and assayed by RT-PCR for the
neural markers Sox2 and neural cell adhesion molecule
(NCAM) (Balak et al., 1987; Kishi et al., 2000) (Fig. 4A).
No induction of either marker is seen in animal caps from
uninjected embryos or in caps to which DEX was not added.
NCAM and Sox2 expression are also absent in caps where
DEX was added at stage 11, consistent with the observation
that neural competence is lost prior to that stage (Knecht et
al., 1995; Lamb et al., 1993; Servetnick and Grainger,
1991a). Also consistent with previous work, BMP antago-
nism beginning at stage 4 or stage 9 induces both Sox2 and
NCAM, indicating neural induction in those animal caps
(Knecht et al., 1995; Lamb et al., 1993). In multiple
experiments, however, we consistently noted weaker neural
induction when DEX was added at stage 9 than at stage 4.
To further examine this, stage 8 animal cap ectoderm was
isolated from DSmad7tevGR/TEV2GR-injected albino
embryos. DEX was added to these cultures at stage 9 or
stage 11, and neural induction was examined by in situ
hybridization for Sox2. We observed no Sox2 induction in
uninjected caps (Fig. 4B), minimal Sox2 expression in
DSmad7tevGR/TEV2GR-injected caps that were not treated
with DEX (Fig. 4C), and expression comparable to
uninduced controls when DEX is added at stage 11
(compare Figs. 4F with C). A large increase in Sox2 levels
is evident in caps from embryos where DEX was added at
stage 4 (Fig. 4D). As suggested by RT-PCR, Sox2 is induced
upon DEX addition at stage 9 (Fig. 4E), but the extent of
induction is decreased relative to stage 4-induced controls,
with the overall area of the cap expressing Sox2 reduced
(compare Figs. 4E with D). Similar results were observedusing NCAM as a neural marker (data not shown). These
results suggest that while BMP antagonism can induce
neural fate in pre-gastrula ectoderm, some restriction in the
ectoderm’s neural competence occurs between stages 4 and
9 of Xenopus development.
The ability of BMP inhibition to induce ectopic neural tissue
in intact embryos is stage dependent
Next, we examined the ability of BMP inhibition to
induce ectopic neural tissue in intact embryos at specific
stages. To ensure that DSmad7tevGR and TEV2GR
efficiently and conditionally antagonize BMP signaling in
the intact embryo, RNA encoding both proteins was injected
into one cell of two-cell stage embryos, along with RNA
encoding green fluorescent protein (GFP) to mark the
injected side (Figs. 5E–H). DEX was added either at stage
5 (16 cells), stage 10 (early gastrula), or stage 14 (early
neurula). The embryos were then collected at stage 16 and
Fig. 5. DEX-dependent inhibition of pSmad1 and of the BMP transcriptional target Msx1. mRNA encoding DSmad7-3TEVGR (300 pg) and TEV2GR (10 pg)
were injected into 1 cell of 2-cell stage embryos. To mark the injected side, mRNA encoding either GFP (A–H) or h-galactosidase (I–L) was also included.
10 AM DEX was added at either St. 5, St. 10, or St. 14, with control embryos cultured in the absence of DEX. When DEX is added, inhibition of Smad1
phosphorylation on the injected side is observed by anti-phosphoSmad1 immunostaining (B–D) and by in situ hybridization forMsx1, a transcriptional target of
BMP signaling (J–K). Little or no effect is observed on either of these markers in controls where no DEX is added (A, I).
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no phospho-Smad1 alteration is observed (arrow, Fig. 5A),
but addition of DEX at stage 5 abolishes Smad1 phosphor-
ylation on the injected side (red arrow, Fig. 5B). DEX
addition at later stages also causes BMP inhibition, as
phospho-Smad1 signal is absent on the injected side upon
addition of DEX at either stage 10 (Fig. 5C) or stage 14
(Fig. 5D).
Next, to confirm that the observed phospho-Smad1
antagonism reflects inhibition of BMP function, we
examined the expression of Msx1, a transcriptional target
of BMP signaling, by in situ hybridization (Suzuki et al.,
1997). DSmad7tevGR/TEV2GR RNAwas injected into one
cell at the two-cell stage, with co-injection of RNA
encoding h-galactosidase (h-gal) marking the injected side.
In the absence of DEX, Msx1 RNA is present on the
injected side (arrow, Fig. 5I), but expression is absent or
reduced upon addition of DEX at stage 5, 10, or 14 (arrows,
Figs. 5J–L). These data, together with the loss of pSmad1
immunostaining in whole embryos, indicate that as in
animal cap ectoderm, DSmad7tevGR/TEV2GR efficiently
inhibits BMP signaling, and can be activated at multiple
stages of development.
To assess the effect of stage-dependent BMP inhibition
on neural induction in intact embryos, DSmad7tevGR and
TEV2GR mRNAs were injected into one cell of two-cell
stage embryos, along with h-gal RNA as a marker of the
injected side. DEX was added either at stage 6 (32-cell),
stage 8 (mid-blastula), stage 9 (late blastula), or stage 11
(mid-gastrula). Embryos were allowed to develop at 148C
until stage 16 (mid-neurula), when they were harvestedand neural development assessed by in situ hybridization
for the neural markers Sox2 and neural cell adhesion
molecule (NCAM) (Balak et al., 1987; Kishi et al., 2000)
(Fig. 6). In the absence of DEX, no neural plate expansion
is observed on the injected side with either marker (Figs.
6A, F). DEX addition at stage 6 or stage 8, laterally
expands the expression domains of both Sox2 and NCAM
(arrows, Figs. 6B, C, G, H), indicating that BMP inhibition
at these stages induces neural development. However,
when DEX is added at stage 9 or later (and BMP signaling
is inhibited by stage 9 + 3 h), ectopic neural tissue is
decreased or absent compared to earlier DEX addition
(arrows, Figs. 6D, E, I, J). Thus, while BMP inhibition
induces neural identity in animal caps and at early stages,
this response is lost in intact embryos between stages 8
and 9, prior to the onset of gastrulation.
Neural crest exhibits stage-dependent responses to BMP
inhibition that are temporally distinct from that of neural
tissue
To further investigate the stage-dependent effects of
BMP inhibition on neural induction, we examined the
expression of several neural plate border markers.
DSmad7tevGR- and TEV2GR-injected embryos were
examined for expression of N-tubulin, a marker of differ-
entiated neurons along the neural plate border (arrow, Fig.
7A) (Chitnis et al., 1995; Woda et al., 2003), and Hairy2a,
a bHLH transcription factor expressed along the neural
plate border and in the neural crest (arrows, Fig. 6E)
(Glavic et al., 2004; Jen et al., 1997). Inhibition of BMP
Fig. 6. Stage-dependent ectopic neural induction by DSmad7TEVGR-mediated BMP inhibition. Embryos were injected with 300 pg DSmad7TEVGR and 10 pg
TEV2GR. After injection, embryos were cultured in the absence of DEX (A, F) or DEX was added at stage 6 (B, G), stage 8 (C, H), stage 9 (D, I), or stage 11
(E, J) and harvested at stage 16. Neural identity was assayed by in situ hybridization for Sox2 (A–E) or NCAM (F–J).
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Hairy2a expression on the injected side (Figs. 7B, F). In
the case of Hairy2a, patchy expression can be seen in the
ventral ectoderm (arrows, Fig. 7F), suggesting that inFig. 7. Effects of DSmad7-mediated stage-dependent BMP inhibition on neu
DSmad7TEVGR RNA and 10 pg TEV2GR RNA and cultured in the absence of D
K, O), or stage 11 (D, H, L, P). The effects of stage-specific BMP inhibition on th
border markers N-tubulin (A–D), and Hairy2a (E–H). Neural crest development w
(I–L), and PDGFRa (M–P). addition to being shifted laterally, the neural border is
disorganized in these embryos. In accordance with our
previous results, these changes in N-tubulin and Hairy2a
expression are not observed when BMP signaling isral crest and neural plate border. Embryos were injected with 300 pg
EX (A, E, I, M), or with DEX added at stage 5 (B, F, J, N), stage 9 (C, G,
e neural plate border were examined by in situ hybridization for the neural
as examined by in situ hybridization for Hairy2a (red arrows, E–H), FoxD3
Table 1
Induction of ectopic neural and neural crest markers by stage-specific BMP
inhibition (# embryos with ectopic expression/total # examined)
No
DEX
DEX,
St. 5
DEX,
St. 9
DEX,
St. 11
Neural markers
(Sox2, NCAM)
2/21
(9%)
32/35
(91%)
5/40
(12%)
3/41
(7%)
Neural crest
markers (FoxD3,
PDGFR, Snail,
Hairy2a)
7/36
(19%)
35/53
(66%)
32/44
(72%)
28/49
(57%)
S. Wawersik et al. / Developmental Biology 277 (2005) 425–442434inhibited at stage 9 or at stage 11 (Figs. 7C, G). In both
cases, N-tubulin expression is present on the injected side,
though this expression is shifted slightly laterally in stage
9 inhibited embryos (Figs. 7C, D). In embryos to which
DEX was added at stage 9, the position of the neural
border as marked by Hairy2a is almost identical to that on
the uninjected side (white arrow, Fig. 7G). However, the
domain of Hairy2a marking neural crest cells is substan-
tially enlarged (red arrow, Fig. 7G). Similar results are
observed on DEX addition at stage 11: Hairy2a expression
along the neural border remains intact, but expression in
the neural crest region is expanded (Fig. 7H).
To ask whether the effect of stage-specific BMP
inhibition on Hairy2a expression in presumptive neural
crest is indicative of changes in neural crest development,
we examined expression of additional early neural crest-
specific markers. FoxD3 encodes a transcription factor
expressed in premigratory neural crest and essential for
normal neural crest development (Sasai et al., 2001). In
uninduced embryos, no FoxD3 alteration is observed on the
injected side (arrow, Fig. 7I). DEX addition at stage 5,
expands FoxD3 expression ventrally (Fig. 7J), with the
domain divided into two regions: a broad dorsal area with
weak expression (asterisk) and a narrow band of high
expression along the ventral edge (arrow). The weak domain
likely represents neural plate expansion, with the region of
high expression corresponding to neural crest formation at
the neural plate border. DEX addition at stage 9 or stage 11
also expands FoxD3 expression, though in a manner distinct
from that caused by BMP inhibition at stage 5. FoxD3
expression is expanded ventrally in stage 9- and stage 11-
treated embryos, with high expression levels throughout the
enlarged domain (red arrows, Figs. 7K, L). However, in
contrast to stage 5-induced embryos, the dorsal limit of
FoxD3 expression is unchanged when DEX is added at
stage 9 or stage 11 (white arrows).
We also examined expression of PDGFRa, a marker of
late neural crest development. (Ho et al., 1994; Soriano,
1997; Tallquist and Soriano, 2003). Like FoxD3 and
Hairy2a, PDGFRa expression is unaffected in the absence
of DEX (Fig. 7M), but is expanded laterally by DEX
addition at stages 5, 9, or 11 (red arrows, Fig. 7N–P). In
addition, the medial edge of PDGFRa expression, which
lies along the neural plate border, is shifted laterally by stage
5 DEX addition, but not by addition at later stages (white
arrows, Figs. 7N–P). Thus, the changes in PDGFRa
expression are consistent with those of FoxD3 and Hairy2a,
indicating that BMP inhibition affects neural crest develop-
ment as late as stage 11. This is in contrast to the effect of
BMP inhibition on neural induction, which is limited to the
period before stage 9. A comparison of the frequency of
ectopic neural and neural crest induction is summarized in
Table 1. These observations confirm that regulated DSmad7
can affect changes in development after stage 8 and suggest
temporally distinct roles for BMP inhibition in neural and
neural crest specification.FGF activation and BMP antagonism induce ectopic neural
expression
One possible explanation for the stage specificity of
ectopic neural induction by DSmad7tevGR/TEV2GR in
intact embryos is that during gastrulation, BMP antago-
nism is modified by additional signals in specifying neural
fate. Members of the FGF family are attractive candidates
for such signals, as FGFs and BMPs interact to influence
the development of a variety of organs (Bei and Maas,
1998; Chen et al., 2000; Zuniga et al., 1999). To ask
whether stage-specific FGF signaling acts in conjunction
with BMP antagonism, we used an inducible form of
FGFR1 (iFGFR1) (Pownall et al., 2003). Rather than
relying on physiological ligand binding, iFGFR1 is
activated by the synthetic dimerizing agent AP20187,
which induces iFGFR dimerization and activates its
downstream signaling pathway. In the absence of AP
20187, iFGFR1 expression in frog embryos does not
induce ectopic Sox2 expression (Fig. 8A). Sox2 is also
unaffected upon iFGFR activation at stage 5 or stage 9
(arrows, Figs. 8B, C). However, iFGFR1 enhanced the
induction of ectopic neural tissue by regulated DSmad7
when the two are activated at stage 5 (compare Figs. 8E to
H). Furthermore, while DSmad7tevGR activation at stage 9
is insufficient for neural induction, activating DSmad
7tevGR and iFGFR1 together at this stage strongly induces
neural development (compare Figs. 8F to H). Stage-
specific neural induction by BMP inhibition and FGF
activation is summarized in Table 2.
FGF signaling has been implicated in Xenopus neural
induction (Hongo et al., 1999; Launay et al., 1996; Pera et
al., 2003). To ask whether this requirement is stage-specific,
we added SU5402, a pharmacological inhibitor of FGF
signaling, to embryos at either stage 9 or stage 11
(Mohammadi et al., 1997; Monsoro-Burq et al., 2003;
Wilson et al., 2000). These embryos were allowed to
develop to stage 16 and the consequences of drug treatment
on neural development were assessed by in situ hybridization
for Sox2 (Fig. 9). Little effect on neural induction was
observed in DMSO-treated control embryos or in embryos to
which SU5402 is added at stage 11 (Figs. 9A, C). Addition
of SU5402 at stage 5 prevents gastrulation, and the effects of
this treatment on neural induction are therefore uninterpret-
Fig. 8. FGF activation must be combined with BMP inhibition to induce ectopic neural expression during gastrulation. Embryos were injected with 20 pg
iFGFR1 RNA (A–C), 300 pg DSmad7TEVGR and 10 pg TEV2GR RNA (D–F), or 20 pg iFGFR1 + 300 pg DSmad7TEVGR/10 pg TEV2GR RNA (G–I).
Inducer (10 AM DEX and/or 1.25 AM AP20187) was added at stage 5 (B, E, H) or stage 9 (C, F, I). In the absence of inducer, ectopic neural induction is not
observed in injected embryos (A, D, G). No ectopic neural induction is observed on the injected side (arrows) in iFGFR1-injected embryos when AP20187 is
added at stage 5 (B) or stage 9 (C). Ectopic neural induction is observed in DSmad7TEVGR/TEV2GR-injected embryos upon addition of DEX at stage 5
(arrow, E), but induction is minimal when DEX is added at stage 9 (arrow, F). FGF activation and BMP inhibition appear to act synergistically, as strong
ectopic neural induction is observed when iFGFR and DSmad7TEVGR/TEV2GR are combined, both when inducer is added at stage 5 (H) or at stage 9 (I).
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stage 11-treated embryos develop normal neural plates. In
embryos treated at stage 9 with SU5402, spina bifida is
apparent in the posterior spinal cord (red arrow, Fig. 9B),
reflecting the role of FGF signaling in gastrulation (Amaya et
al., 1991, 1993). However, a substantial reduction in the size
of the neural plate is also observed (white arrow, Fig. 9B),
with only 28% of these embryos developing normal neural
plates. Thus, together with the synergistic effect of FGF
activation and BMP antagonism, these data suggest a stage-
specific role for FGF signaling in neural induction.
In addition to proposed roles in both the induction and
patterning of neural ectoderm (Holowacz and Sokol, 1999;
Hongo et al., 1999; Ishimura et al., 2000; Koshida et al.,
2002; Launay et al., 1996; Pera et al., 2003; Ribisi et al.,
2000), FGF signals are involved in mesodermal patterningTable 2
Induction of ectopic Sox2 by stage-specific BMP inhibition and FGF
activation (# embryos with ectopic expression/total # examined)
No inducer Inducer, St. 5 Inducer, St. 9
iFGFR1 2/12 (16%) 2/18 (11%) 0/16 (0%)
DSmad7tevGR/
TEV2GR
0/22 (0%) 20/24 (83%) 6/28 (21%)
iFGFR1 +
DSmad7tevGR/
TEV2GR
6/16 (38%) 28/30 (93%) 40/40 (100%)(Amaya et al., 1991, 1993; Cornell and Kimelman, 1994;
Gotoh et al., 1995; Hartley et al., 1994; Isaacs et al., 1994;
Kumano and Smith, 2000; LaBonne and Whitman, 1994,
1997; LaBonne et al., 1995; Slack et al., 1996; Smith et
al., 1993; Weinstein et al., 1998). FGF signaling is also
required for ectodermal patterning by the dorsal and
paraxial mesoderm (Ishimura et al., 2000; Monsoro-Burq
et al., 2003). Therefore, the activation of FGF signaling
may modify BMP-antagonist-mediated neural induction
and development by altering the adjacent mesoderm. To
examine this possibility, we tested the ability of condi-
tional BMP inhibition and FGF activation to induce neural
identity in explanted ectoderm. RNA was injected into
both cells of albino embryos at the two-cell stage and
inducers (DEX and AP20187) were added either at stage 5
or at stage 11. Animal caps were cut at stage 8 and
harvested at stage 16, and neural induction was assessed
by in situ hybridization for Sox2 (Fig. 10). Uninjected
controls showed no Sox2 expression (Fig. 10A). Injected
caps without inducers showed minimal Sox2 induction,
indicating a low level of leakiness in the regulation of
iFGFR and DSmad7tevGR (Fig. 10B). Neural induction is
markedly increased upon addition of inducers at stage 5
(Fig. 10C). In contrast to caps in which BMP is inhibited
alone, FGF activation and BMP inhibition at stage 11 also
induce Sox2 expression (compare Fig. 10D with Fig. 4F),
indicating that, as in the intact embryo, FGF activation
potentiates BMP-antagonist mediated neural induction.
Fig. 9. Inhibition of FGF signaling reduces the size of the neural plate. Embryos were cultured in 0.1 MMR with either 0.005% DMSO (A) or 20 AM
SU5402 + 0.005% DMSO added at stage 9 (B) or stage 11 (C). Neural plate formation was examined by in situ hybridization for Sox2. (A) Control
embryos treated with DMSO exhibit normal neural plates (66/79 normal). (B) Addition of SU5402 at stage 9 causes spina bifida (red arrow) and reduction
of the anterior neural plate (white arrow). Only 27/94 embryos examined exhibited normal-sized anterior neural plates. (C) 61/76 embryos to which SU5402
was added at stage 11 exhibit normal-sized neural plates. Spina bifida is absent in most embryos.
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activation of FGF and inhibition of BMPs, but not by
BMP inhibition alone is further confirmed by RT-PCR
detection of NCAM expression (Fig. 10E). We also note
that the activation of FGF signaling in conjunction with
DSmad7-mediated BMP inhibition leads to elongation of
animals caps, suggesting the induction of mesoderm by
FGF signaling (Isaacs et al., 1994; Smith, 1995; Smith et
al., 1993). Our data are generally consistent with previous
observations on synergy between FGF signaling and BMP
induction on neural induction (Lamb and Harland, 1995),
although in contrast to these authors, we do see brachyury
expression when FGF signaling is activated at stage 11;
this difference may reflect different methods used to
activate FGF signaling in the two studies.
To confirm the induction of mesoderm, we examined
gene expression in injected animal caps by RT-PCR for
Xbra, an immediate early marker of mesoderm induction
(Cunliffe and Smith, 1992; Smith et al., 1991). Xbra
expression is present in caps where FGF signaling is
present, but not in uninduced controls or in caps where
DSmad7 alone has been activated (Fig. 10E). Thus, while
the combination of BMP antagonism and FGF activation
can alter the timing of neural competence in ectodermal
explants, we cannot distinguish between direct neural
induction by FGFs or a mechanism where FGFs induce
and pattern mesoderm that subsequently modifies the
ectoderm’s response to BMP inhibition.Discussion
The BMP gradient model would suggest that, because
neural-inducing BMP antagonists are expressed in the
organizer, BMP-dependent neural/epidermal decisions
should take place during gastrulation, after the organizer
has formed. However, the experiments underlying the
gradient model do not directly address this point, as the
BMP antagonists used are unregulated and active well before
gastrulation, and so cannot answer questions regarding thetiming of signals (Hawley et al., 1995; Marchant et al., 1998;
Wilson and Hemmati-Brivanlou, 1995). To test the hypoth-
esis that BMP inhibition during gastrulation controls neural
induction, we have developed an inducible inhibitor of BMP
signaling. The foundation of this inhibitor is the C-terminal
half of Smad7, DSmad7, which we confirm here to be a
BMP-specific antagonist, blocking Smad1 phosphorylation
without affecting that of Smad2. We also show that when
combined with an inducible tobacco etch virus (TEV)
protease (TEV2GR) DSmad7tevGR, a hormone-inducible
form of DSmad7, acts upstream of Smad1 phosphorylation
to inhibit BMP signaling. This inhibition is rapidly induced,
is cell autonomous, and can be activated at multiple
developmental stages in explanted tissue and in intact
embryos, indicating that DSmad7tevGR and TEV2GR can
be used to functionally examine stage-specific predictions
based on the BMP gradient model.
In intact embryos, BMP inhibition alone is not sufficient for
neural induction during gastrulation
As with unregulated BMP inhibitors, DSmad7tevGR
induces neural markers in animal caps, confirming the
ability of BMP antagonists to drive neurulation in isolated
ectoderm before stage 10.5 (Hawley et al., 1995; Knecht et
al., 1995; Lamb et al., 1993; Wilson and Hemmati-
Brivanlou, 1995). Yet we also show that DSmad7tevGR
activation at stage 9 does not induce neural identity in intact
embryos. This is inconsistent with the BMP gradient model’s
prediction that BMP antagonists alone induce neural identity
during gastrulation, suggesting a more complex mechanism
mediating the neural/epidermal decision.
Two trivial explanations for the loss of BMP-dependent
neural responsiveness in whole embryos are a delay
between DEX addition and maximal activation of DSmad
7tevGR activity and/or an inability of regulated DSmad7 to
completely block Smad1 phosphorylation at post-blastula
stages. If either of these were the case, late-stage DEX
addition might be insufficient to drive neural induction, as
BMP signaling would be only partly inhibited at the time
Fig. 10. FGF activation lengthens the period of neural competence in
animal caps and induces expression of Xbra. Embryos were injected with
20 pg iFGFR1 and 300 pg DSmad7tevGR/10 pg TEV2GR RNA. Inducers
(10 AM DEX and/or 1.25 AM AP20187) were added at stage 5 (C) or stage
11 (D). Animal caps were cut at stage 9 and collected at stage 14, when they
were subjected to either to in situ hybridization for Sox2 or to RT-PCR. No
Sox2 expression is detected in caps from uninjected embryos (A), and
minimal Sox2 is present in caps from injected embryos to which no inducer
was added (B). Strong up-regulation of Sox2 is observed in caps to which
inducers were added at stage 5 (C). Addition of inducers at stage 11 also
strongly activates Sox2 expression (D). This is in contrast to caps from
embryos injected with DSmad7tevGR and TEV2GR and activated at stage
11 (compare with Fig. 4F). Note the elongation in caps induced at both
stage 5 and stage 11 (arrows, C, D), suggesting mesoderm induction due to
the activation of FGF. (F) RT-PCR for NCAM confirms the ability of iFGFR
and DSmad7tevGR, but not DSmad7tevGR alone, to induce neural
development when activated at stage 11. RT-PCR for Xbra further supports
the induction of mesoderm in iFGFR- and DSmad7tevGR/TEV2GR-
injected caps, but not in caps injected with DSmad7tevGR and TEV2GR
alone.
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experiments argue against this. First, DSmad7tevGR acti-
vation as late as stage 14 completely inhibits anti-phospho-
Smad1 immunostaining in both stage 16 animal caps and
whole embryos. Second, activation of DSmad7-mediated
BMP antagonism at stage 9 is sufficient to activate neural-
specific gene expression in animal caps. While this neuralinduction is somewhat weaker than when BMP inhibition
commences at stage 5, it nevertheless argues that DSmad7
activation at late blastula/early gastrula-stages is capable of
inducing neurulation in some contexts. Third, while full
BMP inhibition abolishes expression of the BMP target
gene Msx1, partial inhibition has been reported to have the
opposite effect at the neural plate border (Tribulo et al.,
2003). We show that Msx1 expression is absent in intact
embryos following early- and late-stage DSmad7tevGR/
TEV2GR activation, suggesting complete BMP antago-
nism at both stages. Finally, in animal caps cultured at
148C, DSmad7tevGR-mediated phospho-Smad1 inhibition
is complete by 3 h after DEX addition. At this same
temperature, stages 9 and 10 are separated by approx-
imately 6 h, and stages 9 and 10.5 are separated by more
than 8 h (Nieuwkoop and Faber, 1967). Thus, full
DSmad7tevGR activity is achieved well before both the
onset of gastrulation and the loss of neural competence,
arguing against delayed BMP inhibition as an explanation
for our results.
A second explanation for the stage-dependence of
DSmad7tevGR-mediated neural induction is that neural
specification by BMP antagonists may occur before
gastrulation. In support of this hypothesis, several neural-
inducing genes are expressed in pre-gastrulation embryos
(Kroll et al., 1998; Mizuseki et al., 1998; Penzel et al.,
1997). In addition, some early neural marker expression is
unaffected by inhibition of organizer formation, suggesting
that the organizer is not absolutely required for neural
induction (Wessely et al., 2001). Dorsal–ventral asymmetry
of endogenous Smad1 phosphorylation has been reported as
early as stage 9 (Schohl and Fagotto, 2002), indicating that
BMP signaling is modulated by earlier dorsal determinants.
Chief among these are components of the Wnt signaling
pathway, and ectopic Wnt activation in animal caps is
sufficient to induce neural identity and to repress BMP4
transcription (Baker et al., 1999; Gomez-Skarmeta et al.,
2001). This finding likely reflects a role for h-catenin in
establishing the dorsal–ventral axis, as recent experiments
suggest the h-catenin-dependent formation of a bblastula
Chordin and Noggin expressingQ (BCNE) region in the
dorsal ectoderm by stage 9 (Kuroda et al., 2004). These cells
give rise to a large part of the anterior nervous system, the
floor plate, and the notochord, and explants from this region
taken prior to gastrulation give rise to neural tissue. Taken
together, these observations point towards specification of
neural identity prior to the onset of gastrulation.
While our experiments do not rule out a role for pre-
organizer neural induction, we suggest an additional
possibility: in the intact embryo, signals in addition to
BMP antagonists influence neural induction. In chick
embryos, neural fate acquisition in vivo requires FGF
signaling, and the FGF-inducible neural marker ERNI is
expressed prior to gastrulation, suggesting that FGFs’ role in
neural induction may be quite early in development (Streit
et al., 2000; Wilson et al., 2000). When cultured ectoderm is
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inhibition can rescue neural induction, indicating an
interaction between the two pathways. (Streit et al., 1998;
Wilson et al., 2001). By itself, BMP inhibition in chick does
not induce neural character, but Chordin, a BMP antagonist,
can induce neural identity in ectoderm that has been co-
cultured with the chick organizer, Hensen’s node (Streit et
al., 1998). This capacity correlates with expression of
Churchill (ChCh), a target of the FGF signaling pathway
(Sheng et al., 2003). ChCh is expressed prior to gastrulation
and appears to sensitize early chick ectoderm to neural
inducing signals, supporting the hypothesis that FGF
signaling is important for the initiation of neural competence
before gastrulation. Additional signals, possibly including
BMP antagonists, are then required to maintain neural
character, as FGF signaling alone does not efficiently drive
neural induction in explants (Streit et al., 2000; Wilson et
al., 2000).
In Xenopus, the role for FGFs in neural induction is less
clear. Several studies suggest a requirement for FGF
signaling in posteriorizing neural tissue, but not for its
induction (Holowacz and Sokol, 1999; Ribisi et al., 2000).
On the other hand, dominant negative FGFR-1 blocks BMP
antagonist-mediated neuralization of animal caps, FGF8
overexpression induces ectopic neural tissue, and dominant
negative FGFR-4 inhibits expression of early neural
markers in embryos (Hongo et al., 1999; Launay et al.,
1996; Pera et al., 2003). Here, we present evidence for a
stage-specific requirement for FGFs in neural development,
as pharmacological inhibition of FGF signaling has a
greater inhibitory effect on neural induction at stage 9 than
at stage 11. Moreover, we demonstrate that FGF activation
enhances the neural inductive capacity of BMP inhibition.
We also show that FGF induction removes stage-dependent
restrictions on BMP antagonist-dependent neural formation
in both animal caps and in intact embryos, suggesting that
pre-gastrulation neural fate specification is determined
synergistically by interactions between the BMP and FGF
signaling pathways.
Consistent with a role for the combination of FGF
signaling and BMP antagonism in neural induction, the
Smad1 linker domain contains several MAPK phosphor-
ylation sites (Kretzschmar et al., 1997a). Phosphorylation
of these sites can alter Smad1 transcriptional activity and is
functionally important for neural induction, as mutations
that block MAPK phosphorylation act as dominant
negative regulators of neural development (Pera et al.,
2003; Sater et al., 2003). In stage 10.25 Xenopus embryos,
high levels of phosphorylated MAPK are present in the
organizer, with slightly lower levels in the adjacent
ectoderm (Schohl and Fagotto, 2002), suggesting that in
vivo, FGF signaling acts both on dorsal mesoderm and
dorsal ectoderm. While we find that FGF signaling in
animal caps induces mesoderm, and therefore cannot
determine whether FGFs’ synergistic effects with BMP
inhibition result from direct signaling to the ectoderm orindirect action on the mesoderm, both the interaction
between MAPK and Smad1 and the endogenous MAPK
signaling pattern suggest that FGFs’ effects on neural
induction in whole embryos may be direct.
Regardless of the molecular mechanism, interaction
between the mesoderm and ectoderm presents an explan-
ation for the difference in neural competence in explanted
tissue and intact embryos. Signals from dorsal and paraxial
mesoderm have been shown to influence ectodermal
identity in a variety of contexts (Doniach, 1993; Ishimura
et al., 2000; LaBonne and Bronner-Fraser, 1998; Mancilla
and Mayor, 1996; Marchant et al., 1998; Monsoro-Burq et
al., 2003; Penzel et al., 1997; Poznanski and Keller, 1997;
Servetnick and Grainger, 1991b). Furthermore, Ishimura et
al. (2000) present evidence that in explanted ectoderm,
neural induction by dorsal mesoderm is not blocked by
overexpression of BMP4. Induction was blocked, however,
by the combination of BMP4 and a dominant negative FGF
receptor, suggesting that both signals are involved in
interactions between mesoderm and ectoderm leading to
neural specification. Thus, previous work elucidating the
effects of BMP antagonism in animal caps may have
uncovered a basic mechanism for neural and neural crest
induction, which, in the intact embryo, is refined by
positive and negative regulatory signals from adjacent
tissues.
The gradient hypothesis and timing of neural vs. neural
crest induction
Substantial evidence supports the ability of BMP
signaling to induce distinct ectodermal identities in a
concentration-dependent manner (Barth et al., 1999;
Hawley et al., 1995; Knecht and Harland, 1997; Marchant
et al., 1998; Piccolo et al., 1996; Sasai et al., 1995; Suzuki
et al., 1997; Tribulo et al., 2003; Wilson and Hemmati-
Brivanlou, 1995; Wilson et al., 1997; Woda et al., 2003;
Zimmerman et al., 1996). In addition, in situ examination
reveals that endogenous Smad1 phosphorylation has its
lowest levels near the Spemann organizer and highest
levels in more ventral cells, consistent with a signaling
gradient (Faure et al., 2000; Schohl and Fagotto, 2002).
Thus, it seems likely that a BMP gradient has a role in
dorsoventral patterning. However, mounting evidence,
including the work presented here, suggests that additional
signals affect early neural and neural crest patterning
(Domingos et al., 2001; Holowacz and Sokol, 1999;
Hongo et al., 1999; LaBonne and Bronner-Fraser, 1998;
Launay et al., 1996; Monsoro-Burq et al., 2003; Pera et al.,
2003; Streit and Stern, 1999; Streit et al., 2000; Wilson et
al., 2000, 2001). These signals likely modify the BMP
gradient, giving rise to more temporal and spatial specific-
ity than has previously been appreciated.
It is in this context that we must consider the temporally
distinct specification of neural and neural crest identities.
While temporal differences in neural and neural crest
S. Wawersik et al. / Developmental Biology 277 (2005) 425–442 439specification have been previously noted, the molecular
mechanism underlying such discontinuities was unclear
(Glavic et al., 2004; Servetnick and Grainger, 1991a;
Tribulo et al., 2003; Woda et al., 2003). We show here that
this difference includes the response to BMP antagonism,
which induces neural fate in intact embryos only until stage
8, but ectopic neural crest induction by BMP inhibition
extends to stage 11. As is the case with stage-specific
changes in neural competence, this result could reflect a lag
between DEX addition and complete inhibition of BMP
activity. As outlined above, however, the effects on
phospho-Smad and Msx1 expression, and the time course
of DSmad7tevGR activation argue against partial BMP
inhibition as an explanation for this phenomenon.
While our data do not rule out the function of a single
gradient with distinct action timing in neural and neural crest
cells, they suggest that BMP signals influence cell fate
during multiple, temporally distinct periods. As the neural
plate is specified first, signals from neural cells may
influence the development of adjacent, unspecified neural
crest. Analysis of gene expression points to changes in the
signaling microenvironment at the neural plate border, as
expression of elements of the Notch signaling pathway, as
well as both Bmp4 expression and Smad1 phosphorylation
can be detected at the neural plate border during, but not
before, early neurulation (stage 12–13) (Glavic et al., 2004;
Kurata et al., 2001). In addition,Dlx3, a transcriptional target
of BMP signaling, is required in the non-neural ectoderm for
normal neural crest and neural border development, and
Notch signaling from neural cells affects Bmp4 expression at
the neural plate border (Glavic et al., 2004; Kurata et al.,
2001; Woda et al., 2003). Thus, given the temporal dis-
continuity of neural and neural crest specification, we must
consider a model in which the earlier induced tissue influen-
ces the development of the latter. Rather than patterning the
ectoderm as a single gradient, early BMP signaling may
distinguish broadly between neural and epidermal identities,
while during gastrulation, BMP activity at the neural–
epidermal interface refines this distinction, leading to
specialization of cell types at the neural plate border.
Are FGF activation and BMP inhibition required for neural
induction?
We show here that BMP antagonist-dependent neural
induction in intact embryos is temporally limited and that
during gastrulation, BMP inhibition induces neural identity
only in combination with FGF activation. While these data
suggest a developmentally important interaction between
BMPs and FGFs, they are essentially gain of function, and
therefore do not formally prove the necessity of either signal
in neural induction. In frog, neural formation is inhibited by
ectopic BMP activation or FGF inhibition, suggesting that
both signals are required for normal neural induction
(Hawley et al., 1995; Holowacz and Sokol, 1999; Hongo
et al., 1999; Launay et al., 1996; Pera et al., 2003; Wilsonand Hemmati-Brivanlou, 1995). However, these experi-
ments rely on unregulated FGF antagonists and BMP
activators, which, as our data demonstrate, may not
accurately reflect endogenous development. We observe
stage-specific effects on neural induction upon application
of SU5402, a pharmacological antagonist of FGF signaling.
It should be noted that while SU5402 does affect neural
plate formation in embryos, indicating a role for FGF
signaling in endogenous neural induction, we do not know
whether SU5402 causes a complete block to FGF signaling
in the intact embryo. An even more dramatic effect on
neural plate formation might be possible if such a complete
block were to be achieved. An additional complication in
interpreting the effects of SU5402 in intact embryos stems
from the fact that FGF signaling is involved in mesodermal
development during gastrulation (Amaya et al., 1991, 1993;
Kroll and Amaya, 1996) as well as neural induction, and
therefore some portion of the effects of SU5402 result from
indirect action on mesodermal specification. In neurula
stage embryos, transgenic Bmp4 expression inhibits anterior
neural development, but this strategy activates ectopic
Bmp4 only after gastrulation, precluding conclusions
regarding its effect on neural induction (Hartley et al.,
2001). Even transplantation of beads or cells secreting
BMPs or BMP antagonists must be viewed with caution, as
embryonic wounding rapidly induces MAPK activity, which
may interact with BMP signaling (LaBonne and Whitman,
1997). Thus, while the available evidence suggests that
BMP inhibition and FGF activation are critical in neural
induction, definitive proof requires the generation of cell
autonomous, inducible activators of BMP signaling and
inhibitors of the FGF pathway.
Given the range of events in which BMPs and FGFs are
implicated, understanding morphogenesis requires a knowl-
edge of not only where but when these signals act.
Elucidation of the temporally distinct developmental func-
tions they perform will ultimately yield insights into the
molecular mechanisms that modify and interpret signals and
interacting pathways. The generation of conditional cell
signaling inhibitors and activators represents a significant
step towards this understanding, as it affords temporal con-
trol over the manipulation of signaling pathways, allowing
functional analysis of their timing during development.Acknowledgments
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